Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Cy3 TSA Fluorescence System Kit: High-Sensitivity Signal ...

    2026-01-16

    Cy3 TSA Fluorescence System Kit: High-Sensitivity Signal Amplification for Fluorescence Microscopy

    Executive Summary: The Cy3 TSA Fluorescence System Kit is an advanced tyramide signal amplification kit designed for immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) applications. The kit utilizes horseradish peroxidase (HRP)-catalyzed deposition of Cy3-labeled tyramide, resulting in covalent, high-density labeling at target sites (APExBIO; product page). Cy3 fluorophore properties (excitation 550 nm, emission 570 nm) ensure compatibility with standard fluorescence microscopy. This amplification system reliably enhances the detection of low-abundance proteins and nucleic acids, as demonstrated in both research and peer-reviewed studies (Zhu et al. 2025). All kit components are stably stored at appropriate temperatures, ensuring long-term usability for scientific research (APExBIO).

    Biological Rationale

    Detecting low-abundance biomolecules with high specificity is a cornerstone of modern cellular and molecular biology. Conventional immunofluorescence and hybridization techniques often lack the sensitivity to visualize targets present in low copy numbers. Signal amplification approaches increase detection sensitivity without sacrificing spatial resolution. Tyramide signal amplification (TSA) is especially powerful due to its catalytic and covalent deposition mechanism, limiting signal diffusion and background (Zhu et al. 2025). The Cy3 TSA Fluorescence System Kit leverages this strategy for enhanced detection in fixed tissue and cell samples, supporting studies such as the quantification of lncRNAs, proteins, and other molecular targets in both healthy and disease states.

    Mechanism of Action of Cy3 TSA Fluorescence System Kit

    The Cy3 TSA Fluorescence System Kit (SKU: K1051, APExBIO) employs HRP-labeled secondary antibodies to catalyze tyramide signal amplification. Upon binding, HRP converts Cy3-labeled tyramide into a highly reactive intermediate in the presence of hydrogen peroxide. This intermediate covalently attaches to tyrosine residues on proteins or nucleic acids in the vicinity of the enzyme (product page). The covalent bond formation localizes signal amplification precisely at the antigen or probe site. The Cy3 fluorophore, with excitation at 550 nm and emission at 570 nm, provides bright, photostable fluorescence suitable for most epifluorescence and confocal microscopy setups. The kit includes three main components: Cyanine 3 Tyramide (dry, to be dissolved in DMSO), Amplification Diluent, and Blocking Reagent. Cyanine 3 Tyramide is stored at -20°C protected from light, while the diluent and blocking reagents are stable at 4°C for 2 years, ensuring consistent performance (APExBIO technical data).

    Evidence & Benchmarks

    • The Cy3 TSA Fluorescence System Kit enables detection of low-abundance targets, such as lncRNAs, in formalin-fixed, paraffin-embedded (FFPE) gastric cancer tissues, with signal-to-noise ratios exceeding 10:1 under standard protocols (Zhu et al. 2025).
    • HRP-catalyzed tyramide deposition yields a covalent signal restricted to proximity of the target, minimizing off-target diffusion and background fluorescence (Zhu et al. 2025).
    • The Cy3 fluorophore's excitation/emission maxima (550/570 nm) ensure compatibility with standard TRITC filter sets and most fluorescence microscopy platforms (APExBIO).
    • Benchmarking studies report up to 100-fold signal amplification compared to direct or indirect immunofluorescence without TSA, supporting detection of single-molecule targets (internal review).
    • The product's long-term storage stability (up to 2 years; -20°C for Cy3 tyramide, 4°C for buffers) enables reliable, reproducible results across multi-batch studies (APExBIO).

    This article builds upon prior internal reviews by providing updated peer-reviewed benchmarks and new quantitative detection thresholds. For advanced applications in cancer research, see this analysis which focuses on lipid metabolism, whereas the present article extends coverage to nucleic acid and protein detection in oncology workflows.

    Applications, Limits & Misconceptions

    The Cy3 TSA Fluorescence System Kit is validated for use in:

    • Immunohistochemistry (IHC) for protein localization in fixed tissue sections.
    • Immunocytochemistry (ICC) for detection of cell-surface and intracellular markers.
    • In situ hybridization (ISH) for RNA and DNA probe-based detection, including lncRNA quantification in cancer models (Zhu et al. 2025).

    Peer-reviewed studies have demonstrated its use in detecting Lnc21q22.11 expression in gastric cancer tissues, revealing its utility in both basic and translational research (Zhu et al. 2025).

    Common Pitfalls or Misconceptions

    • Not for live-cell imaging: The kit is optimized for fixed samples; live-cell protocols are not supported due to the requirement for HRP and tyramide substrate stability.
    • Not a quantitative assay by default: Signal intensity reflects both target abundance and enzymatic amplification kinetics; quantification requires proper controls and calibration.
    • Not suitable for multiplexing without careful spectral separation: Cy3 fluorescence may overlap with other red fluorophores (e.g., TRITC); proper filter sets and sequential labeling are required.
    • Not intended for diagnostic or clinical use: As clearly stated by APExBIO, the kit is for research use only and not validated for clinical diagnostics (APExBIO).
    • Background can result from inadequate blocking or excess HRP: Proper blocking and titration of reagents are critical to minimize non-specific signal (internal article).

    Workflow Integration & Parameters

    For optimal results, samples should be fixed (e.g., 4% paraformaldehyde, 10–30 min, RT) and permeabilized. After blocking endogenous peroxidase and non-specific sites, primary antibody or probe incubation is followed by HRP-labeled secondary antibody incubation (typically 1:500 dilution, 1 hr at RT). Cy3 tyramide working solution is freshly prepared in amplification diluent, applied for 10–15 min at RT. Reaction is stopped by washing in PBS. Samples are counterstained and mounted with anti-fade reagent. Imaging is performed using a fluorescence microscope equipped with 550/570 nm filter sets. Protocols should be adapted to tissue thickness, antigen retrieval method, and target abundance. The kit's reagents support up to 2 years of storage under recommended conditions, ensuring reproducibility and batch-to-batch consistency (APExBIO).

    Conclusion & Outlook

    The Cy3 TSA Fluorescence System Kit (APExBIO) establishes a benchmark for sensitive fluorescence amplification in fixed tissue and cell assays. By enabling robust detection of low-abundance nucleic acids and proteins, it supports advanced research in cancer biology, epigenetics, and translational studies. Peer-reviewed evidence confirms its utility in workflows such as the detection of regulatory lncRNAs in gastric cancer models (Zhu et al. 2025). Future innovations may further improve multiplexing and quantitative applications, but this kit remains a foundational tool for high-sensitivity fluorescence microscopy detection.